173 related articles for article (PubMed ID: 10332505)
1. Calcium channel blockers: current controversies and basic mechanisms of action.
Clusin WT; Anderson ME
Adv Pharmacol; 1999; 46():253-96. PubMed ID: 10332505
[No Abstract] [Full Text] [Related]
2. Voltage-gated calcium channels in Pleurodeles oocytes: classification, modulation and functional roles.
Ouadid-Ahidouch H
Zygote; 1998 Feb; 6(1):85-95. PubMed ID: 9652075
[TBL] [Abstract][Full Text] [Related]
3. Calcium channel blockers in myocardial and cerebral ischemia: a clinician's review from bench to bedside.
Borger MA; Weisel RD
Can J Cardiol; 1999 Mar; 15(3):333-40. PubMed ID: 10202197
[TBL] [Abstract][Full Text] [Related]
4. Ca2+ channel subtypes and pharmacology in the kidney.
Hayashi K; Wakino S; Sugano N; Ozawa Y; Homma K; Saruta T
Circ Res; 2007 Feb; 100(3):342-53. PubMed ID: 17307972
[TBL] [Abstract][Full Text] [Related]
5. Vascular effects of calcium channel antagonists: new evidence.
Richard S
Drugs; 2005; 65 Suppl 2():1-10. PubMed ID: 16398057
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis of drug interaction with L-type Ca2+ channels.
Mitterdorfer J; Grabner M; Kraus RL; Hering S; Prinz H; Glossmann H; Striessnig J
J Bioenerg Biomembr; 1998 Aug; 30(4):319-34. PubMed ID: 9758329
[TBL] [Abstract][Full Text] [Related]
7. Pituitary adenylate cyclase-activating polypeptide potentiation of Ca2+ entry via protein kinase C and A pathways in melanotrophs of the pituitary pars intermedia of rats.
Tanaka K; Shibuya I; Harayama N; Nomura M; Kabashima N; Ueta Y; Yamashita H
Endocrinology; 1997 Oct; 138(10):4086-95. PubMed ID: 9322916
[TBL] [Abstract][Full Text] [Related]
8. [Voltage-gated calcium channels].
Kamkin AG; Kiseleva IS; Kirishchuk SI; Lozinskiĭ IT
Usp Fiziol Nauk; 2006; 37(4):3-33. PubMed ID: 17139998
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of catecholamine synthesis inhibition by neuropeptide Y: role of Ca2+ channels and protein kinases.
McCullough LA; Westfall TC
J Neurochem; 1996 Sep; 67(3):1090-9. PubMed ID: 8752116
[TBL] [Abstract][Full Text] [Related]
10. The IVS6 segment of the L-type calcium channel is critical for the action of dihydropyridines and phenylalkylamines.
Schuster A; Lacinová L; Klugbauer N; Ito H; Birnbaumer L; Hofmann F
EMBO J; 1996 May; 15(10):2365-70. PubMed ID: 8665843
[TBL] [Abstract][Full Text] [Related]
11. Voltage-dependent inhibition of N- and P-type calcium channels by the peptide toxin omega-grammotoxin-SIA.
McDonough SI; Lampe RA; Keith RA; Bean BP
Mol Pharmacol; 1997 Dec; 52(6):1095-104. PubMed ID: 9415720
[TBL] [Abstract][Full Text] [Related]
12. A novel voltage-sensitive Na(+) and Ca(2+) channel blocker, NS-7, prevents suppression of cyclic AMP-dependent protein kinase and reduces infarct area in the acute phase of cerebral ischemia in rat.
Tanaka K; Ito D; Suzuki S; Dembo T; Kosakai A; Fukuuchi Y
Brain Res; 2002 Jan; 924(1):98-108. PubMed ID: 11744000
[TBL] [Abstract][Full Text] [Related]
13. Ion channel therapy of ischemic heart disease: from calcium channel blockers to late sodium current inhibition.
Conti CR
Clin Cardiol; 2011 Feb; 34(2):66-7. PubMed ID: 21298648
[TBL] [Abstract][Full Text] [Related]
14. Transfer of 1,4-dihydropyridine sensitivity from L-type to class A (BI) calcium channels.
Grabner M; Wang Z; Hering S; Striessnig J; Glossmann H
Neuron; 1996 Jan; 16(1):207-18. PubMed ID: 8562085
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase A regulates regulates inhibition of N- and P/Q-type calcium channels by ethanol in PC12 cells.
Solem M; McMahon T; Messing RO
J Pharmacol Exp Ther; 1997 Sep; 282(3):1487-95. PubMed ID: 9316863
[TBL] [Abstract][Full Text] [Related]
16. Calcium antagonists and vasodilatation.
Godfraind T
Pharmacol Ther; 1994 Oct; 64(1):37-75. PubMed ID: 7846116
[TBL] [Abstract][Full Text] [Related]
17. [Involvement of calcium channels in the pathogenesis of hypertension].
Murakami M; Iijima T
Nihon Rinsho; 2004 Mar; 62 Suppl 3():152-5. PubMed ID: 15171360
[No Abstract] [Full Text] [Related]
18. Calcium-antagonist drugs.
Abernethy DR; Schwartz JB
N Engl J Med; 1999 Nov; 341(19):1447-57. PubMed ID: 10547409
[No Abstract] [Full Text] [Related]
19. Functional and pharmacological consequences of the distribution of voltage-gated calcium channels in the renal blood vessels.
Hansen PB
Acta Physiol (Oxf); 2013 Apr; 207(4):690-9. PubMed ID: 23351056
[TBL] [Abstract][Full Text] [Related]
20. Voltage-dependent calcium channels.
Lacinová L
Gen Physiol Biophys; 2005 Jun; 24 Suppl 1():1-78. PubMed ID: 16096350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
